The Discounted Cash Flow (DCF) valuation of Moderna Inc (MRNA) is (119.55) USD. With the latest stock price at 25.90 USD, the upside of Moderna Inc based on DCF is -561.6%.
Based on the latest price of 25.90 USD and our DCF valuation, Moderna Inc (MRNA) is a sell. selling MRNA stocks now will result in a potential gain of 561.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.1% - 9.7% | 8.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (246.94) - (80.04) | (119.55) |
| Upside | -1053.4% - -409.0% | -561.6% |